semaglutide clinical trials Injection Protocol for Medical Weight Loss Treatment Troubling Findings in Study of

*J Physiol Paris.* 95(1-6):315-24

Rallison, The time-dependent deformation of a capsule freely suspended in a linear shear flow

Second, GLP-1 reduces the release of glucagon, another hormone that usually raises blood sugar levels

doi: 10.1007/s00394-024-03419-6 184 YueN.HuP.TianC.KongC.ZhaoH.ZhangY.et al

Nature+1 If development continues along its current trajectory, patients will see more peptide drugs, not fewermany of them with sophisticated delivery systems and highly specific indications

In a preprint published on bioRxiv on April 5, 2026, researchers Ulya Keskin, Eslem Altin, Melkan Kagan Kara, Burak Tekin, Kerime Nur Cakircoban, Fikriye Yasemin Ozatik, Neziha Senem Ari, Ayse Kocak Sezgin, and Emre Gungor explored the behavioral and molecular brain-related effects of retatrutide, a novel triple hormone agonist